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Abstract
From previous work, we know that medical practice varies widely, and that unwarranted variation
signals low value for patients and society. We also know that public reporting helps to create
awareness of the need for quality improvement. Despite the availability of rich data, most Western
countries have no routine surveillance of the geographic distribution of utilization, costs, and out-
comes of healthcare, including trends in variation over time. This paper highlights the role of
transparent public reporting as a necessary ﬁrst step to spark change and reduce unwarranted
variation. Two recent examples of public reporting are presented to illustrate possible ways to
reduce unwarranted variation and improve care. We conclude by introducing the Value
Improvement Cycle, which underscores that reporting is only a necessary ﬁrst step, and suggests
a path toward developing a multi-stakeholder approach to change.
Key words: quality improvement < quality management, hospital care < setting of care, practice variations < appropriate
healthcare
Introduction
For over 40 years, health services research has shown that clinical
practice is highly variable across regions, and that this variation is
often unrelated to differences in population need. Practice variation
is considered unwarranted when the variation is not explained by
the incidence of illness, the constraints of medical science, or the pre-
ferences of individuals. Patterns of care are primarily reﬂective of
local practice styles of doctors and health systems [1] and are often
sensitive to the local availability of resources. Brownlee illustrates
this in a study that found ‘an almost-perfect correlation between the
availability of catheterization in a region and the propensity for
patients to be given angioplasty.’ [2] Many more patients received
stents where there were higher numbers of cardiologists
performing angioplasty. At the clinician level, when doctors are
faced with discretionary decisions in standardized vignettes describ-
ing a clinical case, their choices correlate with local health status
adjusted utilization levels [3, 4]. Clinicians adhere to local standards
of care, with the local supply of resources acting as one of the dom-
inant drivers of utilization [5]. As pointed out by Mulley, ‘Clinicians
become accustomed to standard clinical policies that have been
shaped over time by local capacity and are often surprised to learn
that they are radically different from those in other regions.’ [6]
Mapping and reporting regional patterns and investigating geo-
graphic differences in medical utilization are essential for recogniz-
ing problems and developing policies and practices that increase the
value of healthcare. In this era of austerity, the need for greater
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value is acute. ‘One doctor’s waste is another patient’s delay.
Potentially, it could be that other patient’s lack of treatment’ [7].
Public reporting and mapping unwarranted
healthcare variation
The ﬁndings from research into practice variation are rich and
demonstrative of the challenges facing national healthcare systems
[8, 9]. From previous work, we know that unwarranted variation
can be harmful to patients and costly to society [1, 7]. We also
know that patients who live in regions with high costs and high util-
ization rates do not reliably experience better care and outcomes:
more is not always better [10, 11]. These ﬁndings have been par-
tially replicated in a few countries, but in most countries, geographic
data analysis is at the earliest stages, and very few have established
systems for monitoring healthcare value metrics [9] with sufﬁcient
regional and provider speciﬁcity to guide change. There are a few
noteworthy exceptions. In 2010, NHS England began publishing a
series of Atlases [12]. According to the authors, ‘In many localities
across England, the NHS Atlas of Variation in Healthcare series has
been used as a stimulus to start a search for unwarranted variation,
and as a springboard to releasing resources for re-investment in
higher-value healthcare for local patients and populations.’ Another
example is the Dartmouth Atlas of Health Care [13], which found
marked variation in end-of-life care across hospitals in the USA. A
few other countries showed progress in variation research in a recent
Organisation for Economic Co-operation and Development study
[9]. However, in general, most countries do not have clear, valid
and reliable insights into the geographic distribution of the use, costs
and outcomes of healthcare, or into trends over time.
Data statement: ‘Driving Without a Map’
At the fourth annual Wennberg International Collaborative meeting
at Dartmouth College (2013), attendees recognized that the public,
patients, providers, payers and politicians have a common need for
information about healthcare at local and regional levels and
acknowledged that robust data is an essential element of any suc-
cessful clinical transformation initiative. Yet, many of the meeting
attendees reported difﬁculties in accessing existing data, which
restrained efforts to conduct healthcare surveillance in their coun-
tries. In most countries, access to anonymous patient utilization and
cost data for independent research is highly restricted, fragmented
across many data holders, or prohibitively expensive. The reluctance
of the holders of administrative data to share valuable healthcare
data with legitimate researchers and policy analysts diminishes the
prospects for analyzing the performance of regional health systems
and targeting public policy to spur improvement. To promote the
improvement of healthcare through the responsible use of healthcare
data, the Wennberg Collaborative members (n = 45, 23 countries)
signed the statement ‘Driving Without a Map’ at the 2015 London
meeting. Visit for signed text: www.wennbergcollaborative.org/
data-statement.
Avoiding authentic facts
Why is there so often an unwillingness to permit legitimate research-
ers to access healthcare data and freely publish the results they
observe? The most commonly offered reason is to protect patient
privacy. This ignores that protecting patient data is a paramount
concern for all medical and healthcare researchers. Health service
researchers have an excellent track record in demonstrating good
stewardship in securing data. The reluctance to release data is more
likely because medical practice analysis often shows embarrassing
gaps in quality and efﬁciency. Displaying the results at the area or
hospital level is often uncomfortable for clinicians, troubling to
patients, and concerning to politicians. At times, the resistance to
measuring healthcare appears to stem from willful ignorance, a sen-
timent not lost on Berwick, who noted that the concept of unwar-
ranted variation is provocative to clinicians and seen as a direct
challenge to their clinical practice [14]. When data are available,
pushback from providers and insurance plans has been a predictable
response to publicly mapping health system performance.
As analyses move from describing variation toward research into
its causes, intense and valuable discussion often ensues regarding the
implications of the ﬁndings for public policy and clinical improve-
ment. In this dialog, it is crucial that the metrics presented are accur-
ate and that case-mix control between regions or centres is done in a
valid and reliable way. Public reporting can only be effective when
the data and corresponding interpretation are sound.
Does it change anything? And how?
Releasing maps depicting variation stimulates discussion, but the
important question is whether and how change ensues? In the USA,
public reporting has been associated with better healthcare [15], a
review of literature by Agency for Healthcare Research and Quality
concludes. ‘For most of the outcomes, the strength of the evidence
available to assess the impact of public reporting was moderate.’
[15] ‘Studies of healthcare providers’ response to public reports sug-
gest they engage in activities to improve quality when performance
data are made public.’ [15]
Aylin and colleagues [16] showed reduced variation in surgical
rates between Primary Care Trusts in England during the period
from 1998 to 2003 but concluded that ‘the use of surgical proce-
dures still varies widely.’ Appleby et al. [17] found no evidence of
diminishing variation between 2005/2006 and 2009/2010 for hip
replacement, cataract surgery, or tonsillectomy. ‘Variations in tonsil-
lectomy rates may not be as high as the 20-fold variation found by
Glover (1938) across London boroughs in the 1930s, but they
nevertheless remain high.’ [21] All in all, the answer to the question
of whether greater transparency leads to change is incomplete. In
the next section, we present two recent projects from two countries
(the Netherlands and New Zealand) that demonstrate that publish-
ing data is prerequisite to improve care but needs to be accompanied
by other actions.
Reducing regional variation in herniated disc
surgery in the Netherlands
In the past decade, the effect of early spine surgery on outcomes
such as disability scores, pain scores, and patient-reported recovery
in patients with lumbosacral radicular syndrome has been debated.
Randomized controlled trials have shown that early surgery, in com-
parison to medical treatment may result in better one-year out-
comes, but not in better long-term outcomes [18, 19]. Despite
convincing evidence that a conservative approach is good medical
practice, surgery is often seen as the best option in daily practice,
resulting in substantial geographical variation, as reported in both
the USA and the Netherlands [20, 21].
In 2011, data regarding regional and hospital practice variation
in herniated disc surgery in the Netherlands were made public for
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the ﬁrst time. Figure 1a shows that there was substantial variation
in the adjusted and standardized number of herniated disc surgeries
in 2011. The data in Fig. 1a and b shows a decrease in this variation
in surgery rates after publication of these reports. Figure 1a shows
the two hospitals with the highest and lowest indicator scores (i.e.
the age, sex and socio-economic status adjusted number of herniated
disc surgeries per 100 000 persons), as well as the overall mean.
There was a substantial drop in the maximum indicator score and a
slight increase in the minimum indicator score between 2011 and
2014; this means that the surgery rate at the hospital with the most
surgeries per 100 000 adherent persons in 2011 dropped in the years
after, while the rate at the hospital with the lowest number increased
slightly in the years after (Fig. 1a). The difference between the
extremes got smaller. This trend is also reﬂected by the decreasing
factor score, i.e. the ratio between the three highest scoring hospitals
and the three lowest scoring hospitals over time. Between 2011 and
2014, the factor score decreased substantially, from 22.9, 23.2, 19.1
to 12.3. However, despite the decrease in variation between hospi-
tals, the observed total volume was stable over time: 10.650
surgeries in 2011 and 10.175 in 2014. In other words, while the sur-
gical load was redistributed, the total observed volume remained
constant. Figure 1b also shows that, in 2012, a new provider (dotted
line) entered the hospital market, taking a high share of the volume
and affecting the redistribution.
In 2013, the Netherlands adopted the Choosing Wisely (CW)
campaign, and surgeons agreed on a set of ‘wise choices’ in the
treatment of herniated disks that encourage a conservative
approach. It is too early to assess the full impact of CW on volume
and practice variation in herniated disc surgery, but the hypothesis
is that it will lead to further reductions in unwarranted practice
variation.
Reducing variation in opioid use in New Zealand
In New Zealand, dispensing rates of opioids, e.g. oxycodone, increased
by 249% between 2007 and 2011 [22, 23], leading to increasing con-
cern by 2014. The New Zealand Health Quality & Safety Commission
(HQSC) released an Atlas of Health Care Variation that reported dis-
pensing rates of community-dispensed opioids by District Health
Boards (DHBs) in December 2014.
The crucial step in this process was the disclosure of dispensing
rates for all DHBs. The Atlas showed that, in 2013, dispensing rates
of opioids varied by a factor of 2.8 across DHBs (Fig. 2a). The DHB
with the highest rate of strong opioid use was Wairarapa, a small
rural region bordering the capital, Wellington where the lowest rate
was observed. For oxycodone, the rate varied by a factor of 6.5 (see
Fig. 2b). It is unlikely that the observed variation was attributable to
underlying differences in the health status of the populations [22]. A
draft version was sent to all DHBs before being publicly released in
an effort to ensure all data was accurate.
In response to the release of the Atlas, newspapers in the
Wairarapa region immediately picked up on the high prescribing
rates of opioids and published a front-page story. The ﬁndings cre-
ated a ‘burning platform’ for the local Primary Health Organisation
(PHO) to take action. The PHO formed a multi-disciplinary team
and obtained data from the Ministry of Health, as well as local
practice-level data, to better understand the population taking
opioids: by practice, by prescriber, by condition, by age and by eth-
nicity. The team established systems and processes for prescribing
opioids involving patients, general practitioners, and secondary provi-
ders. For example, the emergency department developed a policy that
prescriptions would supply no more than two days of opioids. In the
2016 update of the Atlas, the Wairarapa DHB had signiﬁcantly
reduced rates of strong opioid dispensing, from 30.9 to 24.1 per
1000 inhabitants, and the variation between DHBs was reduced from
a factor of 2.8 to 2.1 (Fig. 2a). Dispensing rates for oxycodone
dropped from 18.8 to 2.7 per capita (Fig. 2b), below the national
average rate. All in all, though the sector was already ‘primed for
change’ regarding opioid prescriptions, the timely public reporting of
data functioned as a ﬁrm nudge and helped to change behavior [24].
What spurs change?
In a seminal article in the Lancet in 1986, Domenighetti et al [25].
wrote that ‘Information on regional rates and on the need for hys-
terectomy given through the mass media to the general population
can change professional practices.’ The annual frequency of hyster-
ectomy rates in the Ticino Canton, Switzerland, was monitored
between 1977 and 1986. ‘From February to October 1984, there
was a public information campaign in the mass media about rates of
Figure 1 (a) Trends in age and sex adjusted number of herniated disc surger-
ies per 100 000 persons, 2011–2014, The Netherlands. (b) Observed volumes
of individual hospitals with high and low volume of herniated disc surgeries,
2011–2014, The Netherlands.
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and need for hysterectomy. After the start of the campaign and dur-
ing the following year the annual rate of operations per 100 000
women of all ages dropped by 25.8%, whereas in the reference area
(Canton Bern), where no information was given to the public, hys-
terectomy rates increased by 1%.’ The Domenighetti study is one of
the very few examples in the medical literature showing that public
reporting and presenting current practice styles to the public fuels
debate and promotes change. This 30-year-old study is both inspir-
ing and challenging for present times. First, it inspires because it
shows the power of going public and giving a role to the mass med-
ia. Second, it confronts us with the fact that this approach is not
used more often. This is partly due to how health services research
works. Analyses of healthcare utilization data, beyond the national
Atlases, are usually presented in academic journals and regrettably,
stay there. Too frequently, meaningful data regarding the perform-
ance of health systems is not presented to the public, or even worse,
not translated from technical terms into the day-to-day language of
the public or politicians.
NHS RightCare claims that awareness is the ﬁrst step, and that
revealing variation is powerful, but it is only the end of the begin-
ning. The key stages beyond that are what and how to change. The
example from UK, through the RightCare programme, demonstrates
how publishing data on variation can be a useful start to a wide-
ranging conversation between clinicians, managers, and patient rep-
resentative groups exploring why variation exists in the local system
and attempting to understand its causes and potential remedies.
Changing persistent patterns of practice variation requires a
debate among stakeholders and an ongoing four-stage process that
we named the Value Improvement Cycle (VIC) (Fig. 3). VIC is simi-
lar to the Plan Do Study Act (PDSA) cycle [26] and to the RightCare
approach, but as the ﬁgure shows, it is speciﬁc to the phenomenon
of practice variation. The PDSA cycle is shorthand for testing a
change by developing a plan to test the change (Plan), carrying out
the test (Do), observing and learning from the consequences (Study),
and determining what modiﬁcations should be made to the test
(Act) [26].
Stage 1 of VIC is devoted to presenting the existing variation
(MAP), using valid and reliable data, adjusting for case mix, and
feeding the data back to the actors responsible for producing it. In
the case of herniated disc surgery, this would mean the surgeons.
Ideally, their response to the data would be ‘we have a problem to
work on.’ Unfortunately, the most common responses are ‘the data
isn’t right,’ ‘my patients are sicker,’ or ‘it may be a problem, but it’s
not mine,’ usually in that order. These so-called ‘stages of grief’ (of
losing professional autonomy) must be processed, one by one. Stage
2—‘can we understand the pattern?’—will only begin when the ﬁrst
step is ﬁnished in a satisfying way.
Stage 2 includes an in-depth analysis by health services research-
ers and a few inﬂuential medical professionals about the meaning of
the data, what causes the variation, and how to understand the
observed pattern in the data (ANALYZE): where are the high and
low use areas, and what variables are associated with utilization dif-
ferences? An important issue here is the assessment of balancing
measures to ensure that, as utilization patterns change, new pro-
blems are not developing elsewhere. For instance, reducing opioid
dispensing rates may cause an increase in return ER visits, or an
apparent reduction in the number of herniated disc surgeries by a
high-volume provider may be partly caused by a change in diagnos-
tic coding practice (e.g. spinal stenosis surgery).
In Stage 3, other stakeholders are involved: referring physicians
(e.g. general practitioners or neurologists in the case of a herniated
disc), payers (e.g. insurers), and patients (SHARE). In this stage, bar-
riers need to be tackled and facilitators activated in order to make
change possible. What and whose value is at stake? This stage ends
in a collectively agreed-upon action, an intervention that differs
between high and low use areas: Stage 4 (CHANGE).
The example from New Zealand provides an excellent model
where all VIC stages were passed. VIC ends and restarts at Stage 1,
where the improvement (reduction of unwarranted practice vari-
ation) is veriﬁed. New data from t + 1 (after the intervention) are
compared to the data at t0. In most cases, this leads to a new round.
Conclusions
In this paper, we point out the fact that, in many countries, there is
limited or no information about unwarranted variation in healthcare
utilization, costs, quality or outcomes, and that additional effort is
needed to convince governments and policymakers that measuring,
and reporting healthcare data is necessary to reduce unwarranted
Figure 2 (a) Strong opiod dispensing rates; total by year, rate by 1000,
2011–2015, New Zealand (red line = national average). (b) People dispensed
oxycodone; total by year, rate by 1000, 2011–2015, New Zealand (red line =
national average).
Figure 3 The Value Improvement Cycle. How to reduce unwarranted
variation?
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variation. There is little evidence that public reporting of healthcare
variation improves care without the engagement of health system
leadership and clinicians. The current paper shows two examples of
how this can be done.
Finally, the paper points out reducing unwarranted variation
and improving care are not always linked. Greater public reporting
and multi-stakeholder interventions may stimulate improvement in
evidence-based care, but at a different pace across regions: health-
care does improve, but variation persists. The sustained surveillance
of healthcare and unwarranted variation provides a powerful
reminder of the need for continual improvement.
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